RVAC Medicines is based in Singapore, Singapore. It has raised $170M in total funding. Backed by CBC Group, Pavilion Capital, EDBI.
RVAC Medicines funding overview
RVAC Medicines is based in Singapore, Singapore. RVAC Medicines has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for RVAC Medicines runs through 2022; nothing later has been disclosed. Investors on record include CBC Group, Pavilion Capital, EDBI, GS Holdings. 4 distinct backers are named across the disclosed rounds.
RVAC Medicines at a glance
Total raised
$170M
Latest round date
April 2022
Headquarters
Singapore, Singapore
Notable investors
CBC Group, Pavilion Capital, EDBI, GS Holdings
Frequently asked about RVAC Medicines funding
How much has RVAC Medicines raised?
RVAC Medicines has raised $170M in total disclosed funding across the rounds on record.
Who has invested in RVAC Medicines?
CBC Group, Pavilion Capital, EDBI, GS Holdings are named among the investors backing RVAC Medicines.
What was the latest RVAC Medicines funding round?
No round stage has been disclosed for RVAC Medicines.
Where is RVAC Medicines based?
RVAC Medicines is based in Singapore, Singapore.
When did RVAC Medicines last raise?
The last disclosed RVAC Medicines round closed in April 2022.
Totals shown for RVAC Medicines aggregate every disclosed round on file. To see how that compares, browse the companies in Singapore and the investors behind them below.
